UltraGreen.ai's Strong Earnings Growth May Continue -- Market Talk

Dow Jones12-05 08:13

0013 GMT - UltraGreen.ai gains a bull in UOB Kay Hian, which expects the indocyanine green supplier to continue seeing strong earnings growth and attractive margins. UltraGreen has delivered robust growth momentum, with operating cash flow surging 113% in 2024 and 33% on year in 1H 2025, say UOB KH analysts in a note. Looking ahead, the analysts forecast three-year CAGR of 21% for revenue and 22% CAGR in earnings over 2024-27, supported by higher procedure volumes, expanding Asia-Pacific penetration and continued premium pricing. Growing clinical evidence, wider availability of near-infrared imaging systems and increasing surgeon training are expected to accelerate the use of indocyanine green, they note. UOB KH initiates coverage on the stock at buy with a target price of US$2.00. (monica.gupta@wsj.com)

(END) Dow Jones Newswires

December 04, 2025 19:13 ET (00:13 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2589855086?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-05 08:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2589855086","market":"sh","top_or_hot":-1,"title":"UltraGreen.ai's Strong Earnings Growth May Continue -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0013 GMT - <a href=\"https://laohu8.com/S/ULG.SI\">UltraGreen.ai</a> gains a bull in UOB Kay Hian, which expects the indocyanine green supplier to continue seeing strong earnings growth and attractive margins. UltraGreen has delivered robust growth momentum, with operating cash flow surging 113% in 2024 and 33% on year in 1H 2025, say UOB KH analysts in a note. Looking ahead, the analysts forecast three-year CAGR of 21% for revenue and 22% CAGR in earnings over 2024-27, supported by higher procedure volumes, expanding Asia-Pacific penetration and continued premium pricing. Growing clinical evidence, wider availability of near-infrared imaging systems and increasing surgeon training are expected to accelerate the use of indocyanine green, they note. UOB KH initiates coverage on the stock at buy with a target price of US$2.00. (monica.gupta@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 04, 2025 19:13 ET (00:13 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UltraGreen.ai's Strong Earnings Growth May Continue -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUltraGreen.ai's Strong Earnings Growth May Continue -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-12-05 08:13</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0013 GMT - <a href=\"https://laohu8.com/S/ULG.SI\">UltraGreen.ai</a> gains a bull in UOB Kay Hian, which expects the indocyanine green supplier to continue seeing strong earnings growth and attractive margins. UltraGreen has delivered robust growth momentum, with operating cash flow surging 113% in 2024 and 33% on year in 1H 2025, say UOB KH analysts in a note. Looking ahead, the analysts forecast three-year CAGR of 21% for revenue and 22% CAGR in earnings over 2024-27, supported by higher procedure volumes, expanding Asia-Pacific penetration and continued premium pricing. Growing clinical evidence, wider availability of near-infrared imaging systems and increasing surgeon training are expected to accelerate the use of indocyanine green, they note. UOB KH initiates coverage on the stock at buy with a target price of US$2.00. (monica.gupta@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 04, 2025 19:13 ET (00:13 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SG9999013478.USD","symbol_name":"利安新加坡股息基金","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2589855086","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2589855086","pubTimestamp":1764893580,"columns":[{"name":"Data Report","id":30,"label_key":"dataReport"}],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0013 GMT - UltraGreen.ai gains a bull in UOB Kay Hian, which expects the indocyanine green supplier to continue seeing strong earnings growth and attractive margins. UltraGreen has delivered robust growth momentum, with operating cash flow surging 113% in 2024 and 33% on year in 1H 2025, say UOB KH analysts in a note. Looking ahead, the analysts forecast three-year CAGR of 21% for revenue and 22% CAGR in earnings over 2024-27, supported by higher procedure volumes, expanding Asia-Pacific penetration and continued premium pricing. Growing clinical evidence, wider availability of near-infrared imaging systems and increasing surgeon training are expected to accelerate the use of indocyanine green, they note. UOB KH initiates coverage on the stock at buy with a target price of US$2.00. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SG9999013478.USD":"利安新加坡股息基金","LU1242518931.SGD":"Fullerton Lux Funds - Asia Absolute Alpha A Acc SGD","SG9999008742.SGD":"Eastspring Investments Unit Trusts - Singapore ASEAN Equity SGD","LU0577902611.USD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"A\" (USD) ACC","SG9999002406.SGD":"利安新加坡信托基金","LU0210637038.USD":"HSBC GIF THAI EQUITY \"AD\" INC","SG9999004220.SGD":"Nikko AM Shenton Asia Dividend Equity Fund  SGD","LU0588545904.SGD":"Eastspring Investments - Asian Equity Income ASDM SGD","LU0577902454.USD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (USD) ACC","LU2506951958.HKD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) INC","LU0878005551.USD":"UBS (LUX) KEY SELEC ASIA ALLOCATION OPPORTUNITY (USD) \"P\" (USD) ACC","LU0577902371.SGD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (SGD) ACC","ULG.SI":"优创康智有限公司","LU0261945553.USD":"FIDELITY ASEAN \"A\" ACC","LU0588545730.USD":"EASTSPRING INVESTMENTS ASIAN EQUITY INCOME \"ADM\" (USD) INC","LU0516422366.SGD":"Fullerton Lux Funds - Asia Focus Equities A Acc SGD","LU0898667661.SGD":"JPMorgan Funds - Asia Pacific Income A (mth) SGD-H","LU0048597586.USD":"富达亚洲焦点A","LU0532188223.SGD":"JPMorgan Funds - ASEAN Equity A (acc) SGD","BK6516":"银行与投资服务概念","LU1130305938.SGD":"Schroder ISF Asian Dividend Maximiser A Dis SGD-H","SG9999016042.SGD":"Schroder Singapore Trust A Acc SGD","LU0516423091.SGD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (SGD) ACC","LU0572939691.SGD":"Janus Henderson Horizon Asian Dividend Income A2 SGD","BK6112":"综合性银行","BK6523":"ESG概念","LU2449936058.SGD":"SUSTAINABLE ASIA EQUITY \"AA\" (SGD) ACC","LU0048573645.USD":"富达东盟基金","LU1105468828.SGD":"Allianz Total Return Asian Equity AM DIS H2-SGD","LU0251143029.SGD":"Fidelity ASEAN A-SGD","SG9999014492.USD":"NIKKO AM ASEAN EQUITY \"A\" (USD) ACC","LU0918141887.USD":"安联亚洲实际收益股票基金","SGXZ58947870.SGD":"LIONGLOBAL SINGAPORE DIVIDEND EQUITY (SGDHDG) INC","SG9999001127.SGD":"United Singapore Growth Fund SGD","LU1988902786.USD":"FULLERTON LUX FUNDS GLOBAL ABSOLUTE ALPHA \"I\" (USD) ACC","SG9999002414.USD":"LIONGLOBAL SINGAPORE TRUST (USD) ACC","LU0516422440.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"A\" (USD) ACC","LU1242518857.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"I\" (USD) ACC","LU0572940350.SGD":"Janus Henderson Horizon Asian Dividend Income A3 SGD","SG9999002679.SGD":"LionGlobal Singapore Balanced SGD","LU0516423174.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (USD) ACC","LU0315178854.USD":"EASTSPRING INVESTMENTS ASIAN EQUITY INCOME \"A\" ACC","LU0831103253.SGD":"JPMorgan Funds - Asia Pacific Income A (mth) SGD","LU0516422952.EUR":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (EUR) ACC","LU0251144936.SGD":"Fidelity Sustainable Asia Equity A-SGD","SG9999013486.USD":"LIONGLOBAL SINGAPORE DIVIDEND EQUITY (USD) INC A","SG9999013460.SGD":"LionGlobal Singapore Dividend Equity Fund SGD","LU2238330802.EUR":"AZ EQUITY - ASEAN COUNTRIES \"AAZ\" (EUR) ACC","LU0577902538.SGD":"Fullerton Lux Funds - Asia Growth and Income Equities A Acc SGD"},"translate_title":"UltraGreen.ai的强劲盈利增长可能会持续——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ULG.SI":0.9},"content_text":"0013 GMT - UltraGreen.ai gains a bull in UOB Kay Hian, which expects the indocyanine green supplier to continue seeing strong earnings growth and attractive margins. UltraGreen has delivered robust growth momentum, with operating cash flow surging 113% in 2024 and 33% on year in 1H 2025, say UOB KH analysts in a note. Looking ahead, the analysts forecast three-year CAGR of 21% for revenue and 22% CAGR in earnings over 2024-27, supported by higher procedure volumes, expanding Asia-Pacific penetration and continued premium pricing. Growing clinical evidence, wider availability of near-infrared imaging systems and increasing surgeon training are expected to accelerate the use of indocyanine green, they note. UOB KH initiates coverage on the stock at buy with a target price of US$2.00. (monica.gupta@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 04, 2025 19:13 ET (00:13 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2589855086","isCrawlerRequest":true}